Literature DB >> 15682492

Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

Lin Jia1, Mei-Hua Zhang.   

Abstract

AIM: To compare the efficacy of probiotic preparation Golden Bifid and lactulose on rat experimental model of minimal hepatic encephalopathy (MHE) induced by thioactamide (TAA).
METHODS: MHE was induced by intraperitoneal injection of TAA (200 mg/kg) every 24 h for two consecutive days. Thirty-six male MHE models were then randomly divided into 3 groups: TAA group (n = 12) received tap water ad libitum only; lactulose group (n = 12) and probiotics group (n = 12) were gavaged, respectively with 8 mL/kg of lactulose and 1.5 g/kg of probiotic preparation Golden Bifid (highly concentrated combination of probiotic) dissolved in 2 mL of normal saline, once a day for 8 d (from the 5(th) d before the experiment to the 3(rd) d of the experiment). The latency of brainstem auditory evoked potentials (BAEP) I was used as an objective index of MHE. The incidence of MHE, the level of serum endotoxin, ammonia, liver function and histological grade of hepatic injury of rats were examined individually.
RESULTS: There were no overt HE and rat deaths in 3 groups. The incidence of MHE, the levels of blood ammonia and endotoxin in TAA group, which were 83.3% (10/12), 168.33+/-15.44 mg/dL and 0.36+/-0.04 EU/mL, respectively, were significantly higher than those in lactulose group, which were 33.3% (4/12), 110.25+/-7.39 mg/dL and 0.19+/-0.02 EU/mL, and probiotics group, which were 33.3% (4/12), 108.58+/-10.24 mg/dL and 0.13+/-0.03 EU/mL respectively (P<0.001). It showed that either probiotics or lactulose could significantly lower the level of hyperammonemia and hyper-endotoxemia, lighten centrolobular necrotic areas as well as inflammatory reaction in the liver of rats, normalize the latency of BAEP, and decrease the incidence of MHE. However, no significant differences were observed between these two groups (P>0.05).
CONCLUSION: Probiotic compound Golden Bifid is at least as useful as lactulose for the prevention and treatment of MHE. Probiotic therapy may be a safe, natural, well-tolerated therapy appropriate for the long-term treatment of MHE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682492      PMCID: PMC4250608          DOI: 10.3748/wjg.v11.i6.908

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Minimal hepatic encephalopathy: natural history, impact on daily functioning, and role of treatment.

Authors:  A Duseja; R K Dhiman; V A Saraswat; Y Chawla
Journal:  Indian J Gastroenterol       Date:  2003-12

Review 2.  Pathophysiology of hepatic encephalopathy.

Authors:  P Ferenci
Journal:  Hepatogastroenterology       Date:  1991-10

3.  Establishment of an animal model of hepatic encephalopathy.

Authors:  C J Chu; F Y Lee; S S Wang; F Y Chang; H C Lin; S L Wu; C C Chan; Y T Tsai; S D Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2000-04

4.  Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.

Authors:  P Brigidi; B Vitali; E Swennen; G Bazzocchi; D Matteuzzi
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy.

Authors:  C Yurdaydin; T J Walsh; H D Engler; J H Ha; Y Li; E A Jones; A S Basile
Journal:  Brain Res       Date:  1995-05-08       Impact factor: 3.252

7.  Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.

Authors:  Qing Liu; Zhong Ping Duan; Da Kang Ha; Stig Bengmark; Jelica Kurtovic; Stephen M Riordan
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

8.  Effect of intrahepatic portal-systemic shunting on hepatic ammonia extraction in patients with cirrhosis.

Authors:  F Nomura; K Ohnishi; H Terabayashi; T Nakai; K Isobe; K Takekoshi; K Okuda
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

Review 9.  Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods.

Authors:  Parampreet S Kharbanda; Vivek A Saraswat; Radha K Dhiman
Journal:  Indian J Gastroenterol       Date:  2003-12

10.  Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.

Authors:  C Loguercio; C Del Vecchio Blanco; M Coltorti
Journal:  J Int Med Res       Date:  1987 Nov-Dec       Impact factor: 1.671

View more
  14 in total

Review 1.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 2.  Probiotics in hepatology.

Authors:  Jan Lata; Jana Jurankova; Marcela Kopacova; Petr Vitek
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 3.  Probiotics in management of hepatic encephalopathy.

Authors:  Barjesh Chander Sharma; Jatinderpal Singh
Journal:  Metab Brain Dis       Date:  2016-04-28       Impact factor: 3.584

4.  Peripheral ammonia as a mediator of methamphetamine neurotoxicity.

Authors:  Laura E Halpin; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

5.  Peripheral ammonia and blood brain barrier structure and function after methamphetamine.

Authors:  Nicole A Northrop; Laura E Halpin; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

6.  Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.

Authors:  Shu-Man Jiang; Lin Jia; Mei-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.

Authors:  Laura E Halpin; Nicole A Northrop; Bryan K Yamamoto
Journal:  Neuropsychopharmacology       Date:  2013-10-29       Impact factor: 7.853

8.  Dopamine Burden Induced the Inactivation of Sonic Hedgehog Signaling to Cognitive Decline in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Jianjing Yang; Xueli Huang; Leping Liu; Jiangnan Hu; Zhu Xu; Qichuan Zhuge
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

Review 9.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

10.  Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy.

Authors:  Saidan Ding; Weilong Huang; Yiru Ye; Jianjing Yang; Jiangnan Hu; Xiaobin Wang; Leping Liu; Qin Lu; Yuanshao Lin
Journal:  Mol Med Rep       Date:  2014-07-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.